SUMMARY The prevalence of seropositivity to Legionella species was studied in 184 children with bronchial asthma and 80 control children, age and sex matched, without respiratory tract infections. The sera were examined by indirect immunofluorescence with antigens of six Legionella species. The asthmatic children showed a significantly high percentage of seroreactions to L pneumophila compared with the control children. In the asthmatic children, no association was found between age, sex, onset of asthmatic symptoms, living conditions, corticosteroid treatment, or exposure to aerosols and seropositivity to Legionella. No relation could be found between the asthma severity score and the titre of serum antibodies to L pneumophila.
Since the aetiological agent of legionnaires' disease was first described in adult patients in 1975,1 a few cases have been reported in childhood.2 4 In a previous survey from our hospital, three of 167 children admitted to hospital for acute respiratory infections, had antibody titres of 1:256 or more to Legionella species at the time of admission; one of these children had asthma.5 Respiratory tract infections have a particularly important impact upon children with asthma. Recently antibody titres of 1:256 or higher to L pneumophila were reported in 29-4% of children with cystic fibrosis.6 A study of 113 adults suffering from chronic pulmonary diseases, including 41 with bronchial asthma, showed a significant increase of serum antibodies to L pneumophila.7
This study was designed to determine whether asthmatic children show a higher incidence of seropositivity to Legionella species compared with non-asthmatic children. Precipitating asthma attacks in children are often associated with symptoms that may be clinically regarded as evidence of upper or lower respiratory infections, but while the role of viral infections in precipitating asthma attacks is already well established, the role of bacterial infections is not yet clear.
As far as we know, this is the first prevalence study of antibodies to Legionella species in children with bronchial asthma.
Patients and methods
Study population. Serum samples were collected during one year (August 1982 to August 1983) from 184 asthmatic children attending the outpatient clinic of the Paediatric Pulmonary-Allergic Service regularly.
The sera were obtained when blood was drawn for other diagnostic examinations. All children were suffering from bronchial asthma according to the criteria of the American Thoracic Society.8 A total of 134 children had perennial extrinsic allergic asthma and 50 had seasonal allergic extrinsic bronchial asthma. All the specimens were collected when the children were free of symptoms. Of the 184 children, 118 (64-14%) were boys and 66 (35.86%) were girls; their ages ranged from 2 to 15 years (mean 8X3 years). The first asthmatic attack had occurred in 56-5% of the patients three or more years before the examination, and in 29-1% of the patients one to two years earlier. The parents were asked to answer a standardised questionnaire on the 225 severity of asthma during the preceding year. An asthma severity score from 1 to 14 was computed for each child, as described by Murray et al.9 Additional information gathered included the number of past admissions to hospital, previous use of mist tents or drug administration by aerosols, and mean age from onset of symptoms. Although corticosteroid treatment is one of the asthma severity score's features, it was considered separately also, because of its particular importance in legionnaires' disease.
Eighty children suffering from various nonrespiratory disorders, or surgical patients, age and sex matched with the study group, served as controls. The study was possible because blood was drawn for other routine examinations; however, informed consent was obtained from the parents of both the study and the control group. All the sera with titres of 1:256 or more were tested for IgE specific antibodies to L pneumophila. We used the immunofluorescent assay first, performed as described for IgG and IgM. Goat antihuman IgE (e chain specific) fluorescein isothiocyanate conjugate was from Miles Yeda, Israel.i2
This antiserum was absorbed before use with a mixture of formalin-killed L pneumophila cells, serogroup 1-4, because it cross reacted with L pneumophila.
The tests for specific IgE for L pneumophila were performed by two enzyme linked immunoassays (ELISA) because we were not in possession of a positive control. The first system was as described by Farshy.'3 The plates used were from Dynatech (M/129/B). They were coated with soluble L pneumophila serogroup 1-4 antigen. 14 Horse radish peroxidase conjugated to goat antihuman IgE (heavy chain specific) was from Miles Yeda, Israel. The results were read spectrophotometrically at 492 nm with a Gilford (2600) spectrophotometer. The second ELISA system used was part of the Platelia total IgE kit for the quantitative determination of total IgE in human serum (Institute Pasteur, Paris). The kit was used as recommended by the manufacturer, in addition to the coated plate method, described above.
Results
The seroreactions of the study groups to L pneumophila are summarised in Table 1 The differences between the frequency of given titres of the asthmatic children versus the healthy children are shown in Fig. 1 . The cumulative distributions are shown in Fig. 2 . The difference between the two groups calculated by Smirnov's test is highly significant (P<0-000001).
Of the 32 positive reactions to L pneumophila (titre 1:256 or more) listed in Table 1 two sera were monovalent (serogroup 1); two reacted equally with serogroups 3 and 4; two reacted equally with serogroups 5 and 6; and one reacted equally with serogroups 1 and 5. Four sera reacted with three serogroups: one of them equally high for serogroups 2 and 4 and less for serogroup 5; two equally high for serogroups 3 and 4 and less for serogroup 6; and one equally high for serogroups 5 and 6 and less for serogroup 2. Nine sera reacted with all monovalent antigens of serogroup 1-4 and six reacted with all serogroups 1-6 with different titres.
Two asthmatic children had titres of 1:64 to L micdadei, one to L bozemanni, and one to L longbeachae. One asthmatic child had a titre of 1:128 for L bozemanii. Three children from the control group had titres of 1:64 for L bozemanii and one had a titre of 1:128 for the same agent. In the asthmatic children, the serological titres were unrelated to age and sex. The mean age and mean age in years from the onset of symptoms are shown in Table 2 . The percentage of children with perennial asthma was more or less constant in each titre group. No association was found between the mean number of years from the onset of the first asthmatic symptoms and the titre group (Table 2) .
Using the asthma history scores versus the titre of serum antibodies to L pneumophila, a regression line, based on all the observations, was computed with the Statistical Analysis System (SAS) general model's procedure (Fig. 3) . The significance level of the intercept is 0-0001 and the slope 0-0003. The correlation coefficient r=0-265.
The 32 sera with titres of 1:256 or more were tested further for IgE specific anti-Legionella antibodies. None of those sera was found reactive by any of the three methods performed. No difference was found between patients with high or low concentrations of IgE. 18 For all these reasons we did not establish cut off limits for seropositivity, but we compared the percentage of asthmatic children seroreacting with a particular titre with the percentage of healthy children seroreacting with the same titre.
The asthmatic children show a very high incidence of seroreactivity to Legionella species compared with children free of respiratory diseases (Table 1, Figs. 1 and 2) and with children with acute respiratory infections,5 from the same hospital.
Our results are highly significant calculated by either x2 test (Table 1) or Smirnov test, which detects discrepancies between two empirical distribution functions. Seropositivity to Legionella belonging to groups other than L pneumophila was very low in our study groups, therefore we analysed statistically only the seroreactions to this.
Previous studies have shown increases in antibody titres during convalescence from legionellosis that were specific for a single serogroup antigen or against antigens common in multiple serogroup strains.'5 19 The seropositive sera in our study cross reacted with the individual antigens belonging to L pneumophila with relatively high frequency; as in the other prevalence studies performed in our area. 17 18 It has been proposed, but not proved, that the common antigen reactions may be secondary reactions on repeat exposure to a different serogroup strain.19
An analysis of the accumulated data on the asthmatic group of children showed no relation between the mean age or between the mean number of years from the onset of the first asthmatic symptoms and the titre group ( Table 2 ).
The correlation coefficient obtained between the asthma severity score and the antibody titre to L pneumophila from the regression line in Fig. 3 20 We have no evidence that the higher seroreactivity of the asthmatic children is due to their higher susceptibility to infection with Legionella. An explanation for the high incidence of seropositivity to Legionella in asthmatic children, could be overactivity of the immune system reflected by raised immunoglobulin concentrations, especially IgE. Using three different techniques, no serum IgE antiLegionella antibodies were detected in the 32 sera with titres equal to or higher than 1:256. No correlation was found between the antibody titre to Legionella and the concentration of total serum IgE of the asthmatic children.
We could not obtain any reference to this subject through the computerised Allergy Service Pharmacia Information Program It should, however, be kept in mind that asthma patients have long term contact with the infected hospital environment, either as outpatients or as inpatients; they are often treated with corticosteroids which have an immunosuppressive character and are frequently inhaling medications through aerosols which are recognised sources for legionnaires' disease. All these together lead to a continuous exposure of asthmatic children to Legionella and could be a contributing factor for their higher incidence in seropositivity than healthy children.
Many febrile respiratory diseases in asthmatic children remain without a differential diagnosis.
